Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8 XW01318
ICD-10-PCS code XW01318 for Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8 is a medical classification as listed by CMS under Anatomical Regions range.
Official Code Descriptor
Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8
Crosswalks
Tabs
No record found
Crosswalk an ICD-10-PCS code to CPT®
Additional/Related Information
Tabs
| Section(X) | Body System(W) | Operation(0) | Body Part(1) | Approach(3) | Device / Substance / Technology(1) | Qualifier(8) |
| New Technology | Anatomical Regions | Introduction | Subcutaneous Tissue | Percutaneous | Daratumumab and Hyaluronidase-fihj | New Technology Group 8 |
No record found
| Change Type | Change Date | Previous Descriptor |
| Code Added | 10-01-2022 |
No need to flip from a code to the front of a book or to hunt through online PDFs to locate applicable chapter and block specific guidelines. See essential instructions from ICD-10-PCS Official Guidelines for Coding and Reporting right on your code details page.
